Fluoroscopy devices produce real-time moving X-ray images of internal structures such as organs, blood vessels, and bones to enable physicians to see how body parts function and move. Dominantly used for angiography, arthrography, myelography, venography, and other procedures, fluoroscopy delivers radiation in low doses over extended periods of time. It helps in diagnosis of issues related to heart, gastrointestinal tract, urinary tract, lungs, joints, and vascular systems. With growing prevalence of disease such as cardiovascular, gastrointestinal, orthopedic disorders and trauma injuries, demand for accurate and minimally invasive diagnostic procedures has surged tremendously. As such, fluoroscopy devices are gaining widespread acceptance due its advantages such as intra-operative visualization, real-time imaging, and radiation dose optimization.

The global Fluoroscopy Devices Market is estimated to be valued at US$ 4720.31 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Growing preference for minimally invasive procedures along with technological advancements are major factors propelling the growth of the fluoroscopy devices market. Miniaturization of fluoroscopy devices, higher image quality with low radiation dose, motion detection and tracking capabilities are some of the latest technologies being integrated. For instance, the launch of premium C-arm systems equipped with flat panel detectors, isocentric C-arms and advanced imaging processing technology not only improves visualization but also enhances workflow efficiency. Furthermore, increasing adoption of biplane systems for complex surgeries and growing penetration of mobile C-arms in ambulatory surgery centers and hospitals are supplementing the market expansion. Considering the benefits of real-time imaging, adoption of fluoroscopy is also rising across ambulatory settings which is creating new revenue streams for market players.

Porter’s Analysis
Threat of new entrants: The setup costs for new entrants in the fluoroscopy devices market is high as the R&D and technology involved is complex. Bargaining power of buyers: Individual buyers have less bargaining power compared to large hospitals and diagnostic centers. Bargaining power of suppliers: A few major players dominate the supply market giving them higher bargaining power. Threat of new substitutes: Alternative medical imaging techniques pose a threat but fluoroscopy still has an edge in real-time imaging. Competitive rivalry: Intense competition exists among the key players to launch innovative products and expand their global footprint.

Key Takeaways

The Global Fluoroscopy Devices Market Demand Is expected to witness high growth. The market in North America currently dominates due to the large patient population undergoing image-guided procedures. Key players operating in the fluoroscopy devices market are Hologic Inc., Siemens Healthcare GmbH, Shimadzu Medical, Koninklijke Philips NV, FUJIFILM Holdings Corporation, Carestream Health, Canon Medical Systems Corporation, General Electric Company (GE Healthcare), and ATON GmbH (Ziehm Imaging Inc. and OrthoScan, Inc.). Regional analysis Asia Pacific is projected to grow at the highest CAGR during the forecast period due to rising healthcare infrastructure, increasing disposable income, and growing geriatric population.

Some of the major players in the fluoroscopy devices market are focusing on mergers and acquisitions to strengthen their geographic presence. For instance, in 2020, FUJIFILM Holdings Corporation acquired Hitachi’s diagnostic imaging business to enhance its product portfolio. Players are also investing in R&D to launch advanced devices with improved imaging quality and reduced radiation dose.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it